article thumbnail

FDA Approves Nitisinone for Treatment of Alkaptonuria

Drug Topics

Episode 8: Stay in Sync with Innovations in Medication Decision Support Drug Topics staff August 6th 2020 Podcast Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

FDA
article thumbnail

Opinion: A bold experiment: Let’s bribe West Virginia to reduce its obesity rate

STAT

More telling, though, is a 2020 report from the Milken Institute reporting that the annual cost of obesity in the United States exceeds $1.4 on health care in 2020. In 2022, the U.S. trillion, or about 34% of the $4.1 billion spent in the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Wyden claims Pfizer used a ‘colossal’ scheme to avoid paying billions in U.S. taxes

STAT

for 2018 and 2020. In what one U.S. lawmaker described as possibly the “largest tax-dodging scheme” by a pharmaceutical company in history, Pfizer sold $20 billion in medicines to U.S. customers, but treating the profits as foreign income for tax purposes.

article thumbnail

STAT+: With $40 million, former DeepMind employees launch startup ‘laser-focused’ on AI protein design

STAT

The Alphabet-owned AI company took the biology world by storm in 2020 with AlphaFold2 , the protein structure prediction AI platform that “solved” a decades-old biology problem. Where is DeepMind’s AI protein design spinout? In 2021, the company spun out Isomorphic Labs, an AI drug discovery company.

article thumbnail

RFK Jr. calls rising autism rate an ‘epidemic.’ Researchers call it a ‘good sign’

STAT

of kids surveyed in 2020 for the previous report. The Centers for Disease Control and Prevention report says that 3.2% of kids surveyed in 2022 have autism spectrum disorder, a slight uptick from the 2.8% The report also confirmed a recent trend that autism prevalence is higher in non-white kids than in white kids. Read the rest…

article thumbnail

FDA’s CRLs reveal 74% of applications rejected for quality, manufacturing issues

Pharma Manufacturing

Out of 202 Complete Response Letters issued between 2020 and 2024, 150 involved quality/manufacturing issues, according to the regulator’s newly released documents.

article thumbnail

Independent Pharmacists’ Unique Role During Disaster Management Efforts

Drug Topics

1 Natural disasters have reached unprecedented levels in the past 5 years, with 2020, 2023, and 2024 being the most destructive and costly since before 1980. One of the most recent natural disasters was the late-2024 and early-2025 Los Angeles wildfires.